Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bowel (colorectal) cancer, Rectal cancer
Closed
Phase 2
This trial is looking at durvalumab for cancer of the back passage (rectal cancer). It is looking at adding it to to shrink the cancer before surgery and reduce the risk of it coming back.
It is for people who have a high risk of their cancer coming back after treatment.
Cancer Research UK supports this trial.
Recruitment start: 15 January 2021
Recruitment end: 24 May 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Mr Campbell Roxburgh
AstraZeneca
Cancer Research UK
University of Glasgow
NHS Greater Glasgow and Clyde
Last reviewed: 15 August 2023
CRUK internal database number: 17187
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
